Month: September 2026

1. What is Rasonque? Rasonque (Daraxonrasib, RMC-6236) is an oral, first-in-class, multi-selective tri-complex “molecular glue” inhibitor designed to selectively target and shut down the active, GTP-bound (“ON”) state of RAS proteins. Developed by Revolution Medicines, it gained breakthrough prominence...